Fluid Biomed, which developed ReSolv™, the world’s first hybrid polymer-metal flow-diverting stent to treat brain aneurysms, has launched its first-in-human clinical trial.
/PRNewswire/ - Fluid Biomed Inc., a medical device company developing ReSolv™, the world s first hybrid polymer-metal flow-diverting stent to treat brain.
Fluid Biotech Inc. Raises $4.7M USD in Oversubscribed Seed Funding Round - read this article along with other careers information, tips and advice on BioSpace
/PRNewswire/ - Fluid Biotech Inc., a medical device start-up company in Calgary, Alberta, Canada, today announced the completion of its Seed fundraising round.